Sale!

Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test

800 د.إ

-20%

The “Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test” is a sophisticated prenatal screening procedure offered by DNA Labs UAE. Priced at 800 AED, this test is designed to assess the risk of Down syndrome (Trisomy 21) in a fetus by analyzing the genetic material in a sample of the mother’s blood. This non-invasive method involves detecting and examining fetal DNA present in the maternal bloodstream to identify any chromosomal abnormalities related to Chromosome 21.

The process begins with a standard maternal serum screening. If the initial results indicate a heightened risk of chromosomal disorders, the test automatically advances to analyze fetal DNA for more definitive information regarding the presence of extra copies of Chromosome 21. This advanced reflex approach minimizes the need for more invasive diagnostic procedures, such as amniocentesis, thus reducing the associated risks.

DNA Labs UAE employs state-of-the-art technology to ensure high accuracy and reliability of the test results, offering expectant parents valuable insights into their baby’s health and aiding in the preparation for any necessary medical interventions or support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MATERNAL SERUM SCREEN 2 ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA MBFD CHROMOSOME 21 Test

Welcome to DNA Labs UAE, where we offer the Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test. This prenatal screening test helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21.

Test Components

  • PAPP-A
  • Free Beta HCG
  • Risk Evaluation
  • MBFD-21

Price

800.0 AED

Sample Condition

3 mL (1.5 mL min.) serum from 1 SST. Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Ship refrigerated or frozen. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along with duly filled Maternal Serum Screen 2 reflex to MBFD-21 consent form (Form 12). Ship refrigerated. DO NOT FREEZE. Valid between 10-13 weeks gestation.

Report Delivery

Dual test: Sample Mon through Sat by 9 am; Report Same day
MBFD-21: Sample Tue by 9 am; Report Next Tue

Method

Chemiluminescent Immunoassay, DNA Sequencing

Test Type

Prenatal Diagnosis

Doctor

Gynecologist

Test Department

Pre Test Information

Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along with duly filled Maternal Serum Screen 2 reflex to MBFD-21 consent form (Form 12). Valid between 10-13 weeks gestation.

Test Details

The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test is a prenatal screening test that helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21. During pregnancy, a small amount of fetal DNA can be found in the mother’s bloodstream. This test utilizes advanced technology to analyze the maternal blood sample and specifically detect any abnormalities in Chromosome 21, such as Down syndrome (Trisomy 21).

The test is typically recommended for pregnant women who have an increased risk of having a baby with chromosomal abnormalities, based on factors like maternal age, family history, or previous abnormal test results. It can also be offered as a follow-up test if an initial screening test suggests a higher risk.

The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test provides a more accurate assessment of the risk compared to traditional screening methods. However, it is important to note that this test is not diagnostic and cannot provide a definitive diagnosis of a chromosomal abnormality. If the test results indicate an increased risk, further diagnostic testing, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the findings.

It is essential to discuss the benefits, limitations, and potential risks of this test with a healthcare provider to make an informed decision about whether to proceed with the Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test.

Test Name MATERNAL SERUM SCREEN 2 ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA MBFD CHROMOSOME 21 Test
Components *PAPP-A*Free Beta HCG*Risk Evaluation *MBFD-21
Price 800.0 AED
Sample Condition 3 mL (1.5 mL min.) serum from 1 SST. Provide maternal Date of birth (dd\/mm\/yy); LMP or Ultrasound; Number of Fetuses (Single\/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy. Ship refrigerated or frozen. All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21\/NIPT along withduly filled Maternal Serum Screen 2 reflex to MBFD-21 consentform (Form 12). Ship refrigerated. DO NOT FREEZE. Valid between 10-13 weeks gestation.
Report Delivery Dual test: Sample Mon through Sat by 9 am; Report Same dayMBFD-21: Sample Tue by 9 am; Report Next Tue
Method Chemiluminescent Immunoassay,DNA Sequencing
Test type Prenatal Diagnosis
Doctor Gynecologist
Test Department:
Pre Test Information Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; Number of Fetuses (Single/Twins); Diabetic status and Body Weight in Kg, IVF, Smoking & Previous history of Trisomy 21 pregnancy.All positive results to submit 10 mL whole blood in a Special tube available from LPL for MBFD-21/NIPT along withduly filled Maternal Serum Screen 2 reflex to MBFD-21 consentform (Form 12). Valid between 10-13 weeks gestation.
Test Details

The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test is a prenatal screening test that helps assess the risk of certain chromosomal abnormalities in a developing fetus, specifically for Chromosome 21.

During pregnancy, a small amount of fetal DNA can be found in the mother’s bloodstream. This test utilizes advanced technology to analyze the maternal blood sample and specifically detect any abnormalities in Chromosome 21, such as Down syndrome (Trisomy 21).

The test is typically recommended for pregnant women who have an increased risk of having a baby with chromosomal abnormalities, based on factors like maternal age, family history, or previous abnormal test results. It can also be offered as a follow-up test if an initial screening test suggests a higher risk.

The Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test provides a more accurate assessment of the risk compared to traditional screening methods. However, it is important to note that this test is not diagnostic and cannot provide a definitive diagnosis of a chromosomal abnormality. If the test results indicate an increased risk, further diagnostic testing, such as amniocentesis or chorionic villus sampling, may be recommended to confirm the findings.

It is essential to discuss the benefits, limitations, and potential risks of this test with a healthcare provider to make an informed decision about whether to proceed with the Maternal Serum Screen 2: Advanced Reflex to Maternal Blood for Fetal DNA (MBFD) Chromosome 21 Test.